Literature DB >> 28580888

Kinetic modelling of [11C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis.

Mattia Veronese1, Tiago Reis Marques2,3, Peter S Bloomfield3, Gaia Rizzo4, Nisha Singh1, Deborah Jones5, Erjon Agushi6, Dominic Mosses6, Alessandra Bertoldo4,7, Oliver Howes2,3, Federico Roncaroli6, Federico E Turkheimer1.   

Abstract

The 18 kDa translocator protein (TSPO) is a marker of microglia activation in the central nervous system and represents the main target of radiotracers for the in vivo quantification of neuroinflammation with positron emission tomography (PET). TSPO PET is methodologically challenging given the heterogeneous distribution of TSPO in blood and brain. Our previous studies with the TSPO tracers [11C]PBR28 and [11C]PK11195 demonstrated that a model accounting for TSPO binding to the endothelium improves the quantification of PET data. Here, we performed a validation of the kinetic model with the additional endothelial compartment through a displacement study. Seven subjects with schizophrenia, all high-affinity binders, underwent two [11C]PBR28 PET scans before and after oral administration of 90 mg of the TSPO ligand XBD173. The addition of the endothelial component provided a signal compartmentalization much more consistent with the underlying biology, as only in this model, the blocking study produced the expected reduction in the tracer concentration of the specific tissue compartment, whereas the non-displaceable compartment remained unchanged. In addition, we also studied TSPO expression in vessels using 3D reconstructions of histological data of frontal lobe and cerebellum, demonstrating that TSPO positive vessels account for 30% of the vascular volume in cortical and white matter.

Entities:  

Keywords:  3D modelling; TSPO; XBD173; [11C]PBR28; endothelium; immunohistochemistry; kinetic modelling

Mesh:

Substances:

Year:  2017        PMID: 28580888      PMCID: PMC6434448          DOI: 10.1177/0271678X17712388

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  47 in total

1.  Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects.

Authors:  K Collste; A Forsberg; A Varrone; N Amini; S Aeinehband; I Yakushev; C Halldin; L Farde; S Cervenka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-22       Impact factor: 9.236

2.  The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker.

Authors:  Andrew Lockhart; Bill Davis; Julian C Matthews; Hassan Rahmoune; Guizhu Hong; Antony Gee; David Earnshaw; John Brown
Journal:  Nucl Med Biol       Date:  2003-02       Impact factor: 2.408

Review 3.  Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?

Authors:  Lucy Vivash; Terence J O'Brien
Journal:  J Nucl Med       Date:  2015-12-23       Impact factor: 10.057

4.  Peripheral benzodiazepine binding sites in platelets of patients affected by mitochondrial diseases and large scale mitochondrial DNA rearrangements.

Authors:  Claudia Martini; Beatrice Chelli; Laura Betti; Marina Montali; Michelangelo Mancuso; Gino Giannaccini; Anna Rocchi; Luigi Murri; Gabriele Siciliano
Journal:  Mol Med       Date:  2002-12       Impact factor: 6.354

5.  Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses.

Authors:  Marie-Caroline Cotel; Ewelina M Lenartowicz; Sridhar Natesan; Michel M Modo; Jonathan D Cooper; Steven C R Williams; Shitij Kapur; Anthony C Vernon
Journal:  Eur Neuropsychopharmacol       Date:  2015-08-17       Impact factor: 4.600

6.  Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study.

Authors:  Bart N van Berckel; Matthijs G Bossong; Ronald Boellaard; Reina Kloet; Alie Schuitemaker; Esther Caspers; Gert Luurtsema; Albert D Windhorst; Wiepke Cahn; Adriaan A Lammertsma; René S Kahn
Journal:  Biol Psychiatry       Date:  2008-06-04       Impact factor: 13.382

7.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies.

Authors:  Federico E Turkheimer; Paul Edison; Nicola Pavese; Federico Roncaroli; Alexander N Anderson; Alexander Hammers; Alexander Gerhard; Rainer Hinz; Yan F Tai; David J Brooks
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

8.  Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.

Authors:  J L E Bird; D Izquierdo-Garcia; J R Davies; J H F Rudd; K C Probst; N Figg; J C Clark; P L Weissberg; A P Davenport; E A Warburton
Journal:  Atherosclerosis       Date:  2009-12-04       Impact factor: 5.162

9.  An anatomically comprehensive atlas of the adult human brain transcriptome.

Authors:  Michael J Hawrylycz; Ed S Lein; Angela L Guillozet-Bongaarts; Elaine H Shen; Lydia Ng; Jeremy A Miller; Louie N van de Lagemaat; Kimberly A Smith; Amanda Ebbert; Zackery L Riley; Chris Abajian; Christian F Beckmann; Amy Bernard; Darren Bertagnolli; Andrew F Boe; Preston M Cartagena; M Mallar Chakravarty; Mike Chapin; Jimmy Chong; Rachel A Dalley; Barry David Daly; Chinh Dang; Suvro Datta; Nick Dee; Tim A Dolbeare; Vance Faber; David Feng; David R Fowler; Jeff Goldy; Benjamin W Gregor; Zeb Haradon; David R Haynor; John G Hohmann; Steve Horvath; Robert E Howard; Andreas Jeromin; Jayson M Jochim; Marty Kinnunen; Christopher Lau; Evan T Lazarz; Changkyu Lee; Tracy A Lemon; Ling Li; Yang Li; John A Morris; Caroline C Overly; Patrick D Parker; Sheana E Parry; Melissa Reding; Joshua J Royall; Jay Schulkin; Pedro Adolfo Sequeira; Clifford R Slaughterbeck; Simon C Smith; Andy J Sodt; Susan M Sunkin; Beryl E Swanson; Marquis P Vawter; Derric Williams; Paul Wohnoutka; H Ronald Zielke; Daniel H Geschwind; Patrick R Hof; Stephen M Smith; Christof Koch; Seth G N Grant; Allan R Jones
Journal:  Nature       Date:  2012-09-20       Impact factor: 49.962

Review 10.  In Vivo Imaging of Human Neuroinflammation.

Authors:  Daniel S Albrecht; Cristina Granziera; Jacob M Hooker; Marco L Loggia
Journal:  ACS Chem Neurosci       Date:  2016-03-25       Impact factor: 4.418

View more
  38 in total

1.  Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate.

Authors:  Nadja Van Camp; Yaël Balbastre; Anne-Sophie Herard; Sonia Lavisse; Clovis Tauber; Catriona Wimberley; Martine Guillermier; Aurélie Berniard; Pauline Gipchtein; Caroline Jan; Romina Aron Badin; Thierry Delzescaux; Philippe Hantraye; Gilles Bonvento
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

2.  In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.

Authors:  Tania Da Silva; Sina Hafizi; Jeremy J Watts; Cynthia Shannon Weickert; Jeffrey H Meyer; Sylvain Houle; Pablo Rusjan; Romina Mizrahi
Journal:  JAMA Psychiatry       Date:  2019-12-01       Impact factor: 21.596

Review 3.  Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.

Authors:  T Notter; J M Coughlin; A Sawa; U Meyer
Journal:  Mol Psychiatry       Date:  2017-12-05       Impact factor: 15.992

4.  Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities.

Authors:  Gaia Rizzo; Mattia Veronese; Matteo Tonietto; Benedetta Bodini; Bruno Stankoff; Catriona Wimberley; Sonia Lavisse; Michel Bottlaender; Peter S Bloomfield; Oliver Howes; Paolo Zanotti-Fregonara; Federico E Turkheimer; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-14       Impact factor: 6.200

5.  Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter.

Authors:  Sujata Sridharan; Joel Raffel; Ashwini Nandoskar; Chris Record; David J Brooks; David Owen; David Sharp; Paolo A Muraro; Roger Gunn; Richard Nicholas
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

6.  Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding.

Authors:  Benjamin B Tournier; Stergios Tsartsalis; Kelly Ceyzériat; Zadith Medina; Ben H Fraser; Marie-Claude Grégoire; Enikö Kövari; Philippe Millet
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-26       Impact factor: 6.200

7.  TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.

Authors:  Hayet Pigeon; Elodie A Pérès; Charles Truillet; Benoit Jego; Fawzi Boumezbeur; Fabien Caillé; Bastian Zinnhardt; Andreas H Jacobs; Denis Le Bihan; Alexandra Winkeler
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

Review 8.  Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System.

Authors:  Ayushi Anna Dinesh; Juned Islam; Javad Khan; Federico Turkheimer; Anthony C Vernon
Journal:  CNS Drugs       Date:  2020-09-25       Impact factor: 5.749

9.  PET Imaging of Human Brown Adipose Tissue with the TSPO Tracer [11C]PBR28.

Authors:  Chongzhao Ran; Daniel S Albrecht; Miriam A Bredella; Jing Yang; Jian Yang; Steven H Liang; Aaron M Cypess; Marco L Loggia; Nazem Atassi; Anna Moore
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

10.  Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.

Authors:  Sudhakar Selvaraj; Peter S Bloomfield; Bo Cao; Mattia Veronese; Federico Turkheimer; Oliver D Howes
Journal:  Schizophr Res       Date:  2017-10-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.